Cargando…
COPD exacerbations by disease severity in England
OBJECTIVES: Exacerbations of chronic obstructive pulmonary disease (COPD) are associated with accelerated disease progression and are important drivers of health care resource utilization. The study aimed to quantify the rates of COPD exacerbations in England and assess health care resource utilizat...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824283/ https://www.ncbi.nlm.nih.gov/pubmed/27099486 http://dx.doi.org/10.2147/COPD.S100250 |
_version_ | 1782426064069328896 |
---|---|
author | Merinopoulou, Evie Raluy-Callado, Mireia Ramagopalan, Sreeram MacLachlan, Sharon Khalid, Javaria Mona |
author_facet | Merinopoulou, Evie Raluy-Callado, Mireia Ramagopalan, Sreeram MacLachlan, Sharon Khalid, Javaria Mona |
author_sort | Merinopoulou, Evie |
collection | PubMed |
description | OBJECTIVES: Exacerbations of chronic obstructive pulmonary disease (COPD) are associated with accelerated disease progression and are important drivers of health care resource utilization. The study aimed to quantify the rates of COPD exacerbations in England and assess health care resource utilization by severity categories according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013. METHODS: Data from the Clinical Practice Research Datalink linked to Hospital Episode Statistics were used to identify patients with a COPD diagnosis aged ≥40 years. Those with complete spirometric, modified Medical Research Council Dyspnea Scale information, and exacerbation history 12 months prior to January 1, 2011 (index date) were classified into GOLD severity groups. Study outcomes over follow-up (up to December 31, 2013) were exacerbation rates and resource utilization (general practitioner visits, hospital admissions). RESULTS: From the 44,201 patients in the study cohort, 83.5% were classified into severity levels GOLD A: 33.8%, GOLD B: 21.0%, GOLD C: 18.1%, and GOLD D: 27.0%. Mean age at diagnosis was 66 years and 52.0% were male. Annual exacerbation rates per person-year increased with severity, from 0.83 (95% confidence interval [CI]: 0.81–0.85) for GOLD A to 2.51 (95% CI: 2.47–2.55) for GOLD D. General practitioner visit rates per person-year also increased with severity, from 4.82 (95% CI: 4.74–4.93) for GOLD A to 7.44 (95% CI: 7.31–7.61) for GOLD D. COPD-related hospitalization rates per person-year increased from less symptoms (GOLD A: 0.28, GOLD C: 0.39) to more symptoms (GOLD B: 0.52, GOLD D: 0.84). CONCLUSION: Patients in the most severe category (GOLD D) experienced nearly three times the number of exacerbations and COPD-related hospitalizations as those in the least severe category (GOLD A), in addition to increased general practitioner visits. Better patient management to stabilize the disease progression could allow for an improvement in exacerbation frequency and a reduction in health care resource utilization. |
format | Online Article Text |
id | pubmed-4824283 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-48242832016-04-20 COPD exacerbations by disease severity in England Merinopoulou, Evie Raluy-Callado, Mireia Ramagopalan, Sreeram MacLachlan, Sharon Khalid, Javaria Mona Int J Chron Obstruct Pulmon Dis Original Research OBJECTIVES: Exacerbations of chronic obstructive pulmonary disease (COPD) are associated with accelerated disease progression and are important drivers of health care resource utilization. The study aimed to quantify the rates of COPD exacerbations in England and assess health care resource utilization by severity categories according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2013. METHODS: Data from the Clinical Practice Research Datalink linked to Hospital Episode Statistics were used to identify patients with a COPD diagnosis aged ≥40 years. Those with complete spirometric, modified Medical Research Council Dyspnea Scale information, and exacerbation history 12 months prior to January 1, 2011 (index date) were classified into GOLD severity groups. Study outcomes over follow-up (up to December 31, 2013) were exacerbation rates and resource utilization (general practitioner visits, hospital admissions). RESULTS: From the 44,201 patients in the study cohort, 83.5% were classified into severity levels GOLD A: 33.8%, GOLD B: 21.0%, GOLD C: 18.1%, and GOLD D: 27.0%. Mean age at diagnosis was 66 years and 52.0% were male. Annual exacerbation rates per person-year increased with severity, from 0.83 (95% confidence interval [CI]: 0.81–0.85) for GOLD A to 2.51 (95% CI: 2.47–2.55) for GOLD D. General practitioner visit rates per person-year also increased with severity, from 4.82 (95% CI: 4.74–4.93) for GOLD A to 7.44 (95% CI: 7.31–7.61) for GOLD D. COPD-related hospitalization rates per person-year increased from less symptoms (GOLD A: 0.28, GOLD C: 0.39) to more symptoms (GOLD B: 0.52, GOLD D: 0.84). CONCLUSION: Patients in the most severe category (GOLD D) experienced nearly three times the number of exacerbations and COPD-related hospitalizations as those in the least severe category (GOLD A), in addition to increased general practitioner visits. Better patient management to stabilize the disease progression could allow for an improvement in exacerbation frequency and a reduction in health care resource utilization. Dove Medical Press 2016-04-01 /pmc/articles/PMC4824283/ /pubmed/27099486 http://dx.doi.org/10.2147/COPD.S100250 Text en © 2016 Merinopoulou et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Merinopoulou, Evie Raluy-Callado, Mireia Ramagopalan, Sreeram MacLachlan, Sharon Khalid, Javaria Mona COPD exacerbations by disease severity in England |
title | COPD exacerbations by disease severity in England |
title_full | COPD exacerbations by disease severity in England |
title_fullStr | COPD exacerbations by disease severity in England |
title_full_unstemmed | COPD exacerbations by disease severity in England |
title_short | COPD exacerbations by disease severity in England |
title_sort | copd exacerbations by disease severity in england |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4824283/ https://www.ncbi.nlm.nih.gov/pubmed/27099486 http://dx.doi.org/10.2147/COPD.S100250 |
work_keys_str_mv | AT merinopoulouevie copdexacerbationsbydiseaseseverityinengland AT raluycalladomireia copdexacerbationsbydiseaseseverityinengland AT ramagopalansreeram copdexacerbationsbydiseaseseverityinengland AT maclachlansharon copdexacerbationsbydiseaseseverityinengland AT khalidjavariamona copdexacerbationsbydiseaseseverityinengland |